NCT06233227View on ClinicalTrials.gov

Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 24, 2024

Primary Completion Date

November 18, 2024

Study Completion Date

December 16, 2024

Conditions
Healthy Subjects
Interventions
DRUG

Dutasteride-Test product

Dutasteride soft capsule 0.5 mg Test product Manufactured by: Phil Inter Pharma Co., Ltd., Vietnam

DRUG

Dutasteride-Reference product

Dutasteride soft capsule 0.5 mg Reference product Manufactured by: DELPHARM POZNAN S.A., Poland

All Listed Sponsors
lead

Bio-innova Co., Ltd

INDUSTRY

NCT06233227 - Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule | Biotech Hunter | Biotech Hunter